
Ryght AI is revolutionizing clinical trials with its AI-powered platform that streamlines operations and accelerates timelines. The company has developed an AI digital twin of every clinical trial site globally, enabling efficient site identification, feasibility, selection, and activation. By leveraging generative AI, Ryght AI helps sponsors, CROs, and research sites to enhance their operations, reduce competition, and improve patient enrollment. The platform is designed to connect research sites with trial sponsors and CROs, making the clinical research process faster and more efficient. With a strong focus on healthcare and life sciences, Ryght AI is positioned to transform the industry and improve patient outcomes.

Ryght AI is revolutionizing clinical trials with its AI-powered platform that streamlines operations and accelerates timelines. The company has developed an AI digital twin of every clinical trial site globally, enabling efficient site identification, feasibility, selection, and activation. By leveraging generative AI, Ryght AI helps sponsors, CROs, and research sites to enhance their operations, reduce competition, and improve patient enrollment. The platform is designed to connect research sites with trial sponsors and CROs, making the clinical research process faster and more efficient. With a strong focus on healthcare and life sciences, Ryght AI is positioned to transform the industry and improve patient outcomes.
What they do: Enterprise GenAI platform creating AI 'digital twins' of clinical research sites to accelerate clinical trials
Headquarters: Anaheim / Laguna Beach, California
Founding year: 2023
Founders / leaders: Simon Arkell (Co‑Founder & CEO), Alex Dickinson (Co‑Founder & Chairman)
Employees: 21
Known funding: Seed rounds (multiple); total reported ~$5.5M; latest seed announced Jun 12, 2025
Clinical trials operations and site selection/enrollment optimization for biopharma and CROs
2023
Healthcare / Life Sciences
Launch press release announcing seed funding
Reported additional seed activity (Nov 2023)
3000000.00
Seed round reported June 12, 2025
“Mixed institutional and strategic seed investors including Virtue, Foothill Ventures, AIX Ventures, Iaso/Iaso Ventures, Page One Ventures, Top Harvest Capital; strategic investor/advisor participation from Tarek Sherif and Accenture (reported partnership/investment)”